Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK) After KOL Feedback Oct 20, 2026 09:24AM
U.S. biotech SMids: Q3 earnings preview Oct 18, 2026 08:00PM
Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK) Oct 13, 2026 09:03AM
Raymond James Reiterates Strong Buy Rating on Scholar Rock (SRRK) Oct 8, 2026 09:51AM
Piper Sandler on Scholar Rock (SRRK): 'Survey Supports Broad ISEMBYLD Uptake' Sep 25, 2026 08:23AM
View Older Stories

Sep 24, 2026 08:51AM Scholar Rock (SRRK) PT Raised to $77 at Truist Securities
Sep 21, 2026 06:31AM Scholar Rock (SRRK) PT Raised to $70 at JPMorgan
Sep 15, 2026 11:00AM Scholar Rock (SRRK) PT Raised to $75; Piper Sandler: 'Buying the Dip'
Sep 15, 2026 09:16AM UBS Reiterates Buy Rating on Scholar Rock (SRRK)
Sep 15, 2026 07:21AM Scholar Rock (SRRK) PT Raised to $70 at H.C. Wainwright
Sep 15, 2026 03:49AM Barclays Downgrades Scholar Rock (SRRK) to Equalweight
Sep 14, 2026 12:20PM TD Cowen Reiterates Buy Rating on Scholar Rock (SRRK)
Sep 14, 2026 10:44AM Scholar Rock (SRRK) PT Raised to $70 at Wedbush
Sep 14, 2026 05:56AM Scholar Rock (SRRK) PT Raised to $76 at Truist Securities
Sep 14, 2026 05:35AM Scholar Rock (SRRK) PT Raised to $72 at Raymond James
Sep 10, 2026 09:37AM BMO Capital Reiterates Outperform Rating on Scholar Rock (SRRK)
Sep 8, 2026 07:53AM H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK)
Sep 2, 2026 08:02AM Scholar Rock gets FDA fast track for apitegromab in rare muscle disease
Aug 24, 2026 09:28AM BMO Capital Reiterates Outperform Rating on Scholar Rock (SRRK)
Aug 21, 2026 09:06AM Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
Aug 10, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK)
Aug 6, 2026 07:40AM Scholar Rock Holding Corp. (SRRK) Tops Q2 EPS by 1c
Jun 18, 2026 06:57AM Scholar Rock (SRRK) Reiterated at Overweight by Cantor Fitzgerald
May 7, 2026 07:22AM Scholar Rock Holding Corp. (SRRK) Misses Q1 EPS by 3c
May 6, 2026 06:13AM Evercore ISI Starts Scholar Rock (SRRK) at Outperform
Apr 1, 2026 12:49PM Scholar Rock (SRRK) PT Raised to $57 at Jefferies
Mar 31, 2026 12:22PM Scholar Rock (SRRK) PT Raised to $58 at BofA Securities
Mar 31, 2026 11:08AM Scholar Rock (SRRK) PT Raised to $60 at Raymond James
Mar 31, 2026 07:01AM Scholar Rock resubmits drug application to FDA for SMA treatment
Mar 19, 2026 05:39PM Truist Securities on Scholar Rock (SRRK): today's Roche news 'neutral to positive'
Mar 19, 2026 05:05PM BMO Capital on Scholar Rock (SRRK): emugrobart discontinuation a 'strong positive'
Mar 19, 2026 02:11PM Cantor Fitzgerald: 'We now expect apitegromab to have near complete market share'
Mar 16, 2026 07:38AM Scholar Rock (SRRK) PT Raised to $50 at JPMorgan
Mar 4, 2026 07:55AM 'We are incrementally positive on Scholar Rock (SRRK) Shares'; PT Raised at Piper Sandler
Mar 3, 2026 04:10PM Scholar Rock (SRRK) PT Raised to $50 at Leerink Partners
Mar 3, 2026 04:01PM Scholar Rock (SRRK) PT Raised to $53 at Barclays
Mar 3, 2026 01:54PM Scholar Rock (SRRK) PT Raised to $55 at Truist Securities
Mar 3, 2026 01:34PM Raymond James Reiterates Strong Buy Rating on Scholar Rock (SRRK)
Mar 3, 2026 12:49PM Scholar Rock (SRRK) PT Raised to $70 at BMO Capital
Mar 3, 2026 07:02AM Scholar Rock Holding Corp. (SRRK) Tops Q4 EPS by 2c
Jan 26, 2026 06:47AM Scholar Rock (SRRK) PT Raised to $58 at H.C. Wainwright
Jan 12, 2026 07:05AM Scholar Rock targets 2026 apitegromab BLA resubmission and launch
Jan 9, 2026 05:01AM Citi Starts Scholar Rock (SRRK) at Buy
Jan 7, 2026 01:02AM UBS Starts Scholar Rock (SRRK) at Buy
Dec 11, 2025 07:18AM Scholar Rock's (SRRK) Apitegromab Approval Certain - Cantor Fitzgerald
Nov 17, 2025 04:15PM Wolfe Research Starts Scholar Rock (SRRK) at Outperform
Nov 17, 2025 08:13AM Scholar Rock (SRRK) PT Raised to $50 at BMO Capital
Nov 14, 2025 07:03AM Scholar Rock Holding Corp. (SRRK) Misses Q3 EPS by 6c
Oct 20, 2025 08:30AM Scholar Rock (SRRK) PT Lowered to $44 at Truist Securities
Oct 14, 2025 07:29AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)
Oct 13, 2025 11:16AM Scholar Rock stock falls after FDA flags issues at manufacturing facility
Oct 9, 2025 06:11AM BofA Securities Starts Scholar Rock (SRRK) at Buy
Sep 24, 2025 08:59AM Truist on Scholar Rock (SRRK): 'We See Today's Stock Weakness as a Buying Opportunity'
Sep 24, 2025 08:39AM Scholar Rock (SRRK) PT Lowered to $51 at Piper Sandler
Sep 24, 2025 06:39AM Scholar Rock (SRRK) PT Lowered to $44 at H.C. Wainwright
View Older Stories